商品
搜索
首页
百科
3,4-di-O-(p-methoxybenzyl)-6-O-trityl-D-galactal
CAS号:1442681-53-9
英文名:3,4-di-O-(p-methoxybenzyl)-6-O-trityl-D-galactal
分子式
C41H40O6
熔点
密度
分子量
628.753
沸点
溶解度
信号词
危险品标志
若想填写更详细的询价信息,请
点击进入询价页面
点我
产品名称/CAS号
纯度
需求量
立即询价
基本信息
中文名称
3,4-di-O-(p-methoxybenzyl)-6-O-trityl-D-galactal
英文名称
3,4-di-O-(p-methoxybenzyl)-6-O-trityl-D-galactal
中文别名
英文别名
CAS号
1442681-53-9
分子式
C41H40O6
分子量
628.753
精确质量
628.282
PSA
55.38
LOGP
8.0956
下游产品
共找到
35
个下游商品 >
1442681-39-1
5-((2S,4R,5S)-2-(4-methoxyphenyl)-5-((S)-3-methyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-7-yl)-1,3-dioxolan-4-yl)-N,N-dimethylpyrimidin-2-amine
1442681-15-3
(1R,2S)-1-(2-(dimethylamino)pyrimidin-5-yl)-2-((S)-3-ethyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-7-yl)ethane-1,2-diol
1442680-05-8
(2R,3S,4R)-3,4-bis((4-methoxybenzyl)oxy)-4-(1-methyl-1H-pyrazol-4-yl)-1-(trityloxy)butan-2-ol
1442681-37-9
5-((2R,4R,5S)-2-(4-methoxyphenyl)-5-((S)-3-methyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-7-yl)-1,3-dioxolan-4-yl)-N,N-dimethylpyrimidin-2-amine
1442681-18-6
(1R,2S)-1-(2-(dimethylamino)pyrimidin-5-yl)-2-((S)-3-phenyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-7-yl)ethane-1,2-diol
1442681-30-2
(1R,2S)-1-(2-(4-chlorophenyl)pyrimidin-5-yl)-2-((S)-3-methyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-7-yl)ethane-1,2-diol
下游产品
5-((2S,4R,5S)-2-(4-methoxyphenyl)-5-((S)-3-methyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-7-yl)-1,3-dioxolan-4-yl)-N,N-dimethylpyrimidin-2-amine
(1R,2S)-1-(2-(dimethylamino)pyrimidin-5-yl)-2-((S)-3-ethyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-7-yl)ethane-1,2-diol
(2R,3S,4R)-3,4-bis((4-methoxybenzyl)oxy)-4-(1-methyl-1H-pyrazol-4-yl)-1-(trityloxy)butan-2-ol
5-((2R,4R,5S)-2-(4-methoxyphenyl)-5-((S)-3-methyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-7-yl)-1,3-dioxolan-4-yl)-N,N-dimethylpyrimidin-2-amine
(1R,2S)-1-(2-(dimethylamino)pyrimidin-5-yl)-2-((S)-3-phenyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-7-yl)ethane-1,2-diol
(1R,2S)-1-(2-(4-chlorophenyl)pyrimidin-5-yl)-2-((S)-3-methyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-7-yl)ethane-1,2-diol
(1R,2S)-1-(2-(dimethylamino)pyrimidin-5-yl)-2-((S)-3-methyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-7-yl)ethane-1,2-diol
(1R,2S)-1-(1-methyl-1H-pyrazol-4-yl)-2-((S)-3-methyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-7-yl)ethane-1,2-diol
(S)-7-((1S,2R)-1,2-bis((4-methoxybenzyl)oxy)-2-(1-methyl-1H-pyrazol-4-yl)ethyl)-3-phenyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-4-one
5-((1R,2S)-1,2-bis((4-methoxybenzyl)oxy)-2-((S)-3-phenyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-7-yl)ethyl)-N,N-dimethylpyrimidin-2-amine
5-((1R,2S)-1,2-bis((4-methoxybenzyl)oxy)-2-((S)-3-(4-methoxyphenyl)-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-7-yl)ethyl)-N,N-dimethylpyrimidin-2-amine
(S)-7-((1S,2R)-2-(2-(4-chlorophenyl)pyrimidin-5-yl)-1,2-bis((4-methoxybenzyl)oxy)ethyl)-3-methyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-4-one
(S)-7-((1S,2R)-1,2-bis((4-methoxybenzyl)oxy)-2-(1-methyl-1H-pyrazol-4-yl)ethyl)-3-methyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-4-one
(2R,3S,4R)-4-(2-aminopyrimidin-5-yl)-3,4-bis((4-methoxybenzyl)oxy)-1-(trityloxy)butan-2-ol
5-((1R,2S)-2-((S)-3-(4-fluorophenyl)-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-7-yl)-1,2-bis((4-methoxybenzyl)oxy)ethyl)-N,N-dimethylpyrimidin-2-amine
5-((1R,2S)-1,2-bis((4-methoxybenzyl)oxy)-2-((S)-3-(thiophen-2-yl)-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-7-yl)ethyl)-N,N-dimethylpyrimidin-2-amine
(1R,2S)-1-(2-(dimethylamino)pyrimidin-5-yl)-2-((S)-3-(4-methoxyphenyl)-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-7-yl)ethane-1,2-diol
(1R,2S)-1-(2-(dimethylamino)pyrimidin-5-yl)-2-((S)-3-methyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-7-yl)ethane-1,2-diyl diacetate
(1R,2S)-1-(2-(dimethylamino)pyrimidin-5-yl)-2-((S)-3-(thiophen-2-yl)-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-7-yl)ethane-1,2-diol
(S)-7-((1S,2R)-2-(2-(4-chlorophenyl)pyrimidin-5-yl)-1,2-bis((4-methoxybenzyl)oxy)ethyl)-3-ethyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-4-one
(1R,2S)-1-(2-(dimethylamino)pyrimidin-5-yl)-2-((S)-3-(4-fluorophenyl)-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-7-yl)ethane-1,2-diol
(2R,3R,4R)-4-(2-(dimethylamino)pyrimidin-5-yl)-3,4-bis((4-methoxybenzyl)oxy)-1-(trityloxy)butan-2-ol
(2R,3S,4R)-4-(2-(4-chlorophenyl)pyrimidin-5-yl)-3,4-bis((4-methoxybenzyl)oxy)-1-(trityloxy)butan-2-ol
5-((1R,2S)-2-((S)-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-7-yl)-1,2-bis((4-methoxybenzyl)oxy)ethyl)-N,N-dimethylpyrimidin-2-amine
(S)-7-((1S,2R)-1,2-bis((4-methoxybenzyl)oxy)-2-(1-methyl-1H-pyrazol-4-yl)ethyl)-3-methyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazine
5-((1R,2S)-2-((S)-3-ethyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-7-yl)-1,2-bis((4-methoxybenzyl)oxy)ethyl)-N,N-dimethylpyrimidin-2-amine
(S)-7-((1S,2R)-2-(2-(4-chlorophenyl)pyrimidin-5-yl)-1,2-bis((4-methoxybenzyl)oxy)ethyl)-3-methyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazine
(S)-7-((1S,2R)-1,2-bis((4-methoxybenzyl)oxy)-2-(2-methylpyrazolo[1,5-a]pyrimidin-6-yl)ethyl)-3-methyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazine
(1S,2R)-1-((S)-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-7-yl)-2-(2-(dimethylamino)pyrimidin-5-yl)ethane-1,2-diol
(2R,3S,4R)-4-(2-(dimethylamino)pyrimidin-5-yl)-3,4-bis((4-methoxybenzyl)oxy)-1-(trityloxy)butan-2-ol
(2R,3S,4R)-3,4-bis((4-methoxybenzyl)oxy)-4-(2-phenylpyrazolo[1,5-a]pyrimidin-6-yl)-1-(trityloxy)butan-2-ol
(2R,3S,4R)-3,4-bis((4-methoxybenzyl)oxy)-4-(1-phenyl-1H-pyrazol-4-yl)-1-(trityloxy)butan-2-ol
5-((1R,2S)-1,2-bis((4-methoxybenzyl)oxy)-2-((S)-3-methyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-7-yl)ethyl)-N,N-dimethylpyrimidin-2-amine
(2R,3S,4R)-3,4-bis((4-methoxybenzyl)oxy)-4-(2-methylpyrazolo[1,5-a]pyrimidin-6-yl)-1-(trityloxy)butan-2-ol
(S)-7-((1S,2R)-2-(2-(dimethylamino)pyrimidin-5-yl)-1,2-bis((4-methoxybenzyl)oxy)ethyl)-3-methyl-6,7-dihydro-4H-[1,2,3]triazolo[5,1-c][1,4]oxazin-4-one